The activation of β2-adrenergic receptors in naïve rats causes a reduction of blood glutamate levels: Relevance to stress and neuroprotection

Neurochemical Research

Volumn 36, Issue 5, 2011, Pages 732-738

  Zlotnik, Alexander ^a   Klin, Yael ^b   Gruenbaum, Benjamin F ^a   Gruenbaum, Shaun E ^c   Ohayon, Sharon ^a   Boyko, Mathew ^a   Sheiner, Eyal ^a   Aricha Tamir, Barak ^a   Shapira, Yoram ^a   Teichberg, Vivian I ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 Adrenergic receptors; Glutamate; Recovery; Traumatic brain injury

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BUTOXAMINE; GLUTAMIC ACID; ISOPRENALINE; METOPROLOL; PROPRANOLOL;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; STRESS;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BUTOXAMINE; GLUTAMIC ACID; MALE; METOPROLOL; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-2; STRESS, PHYSIOLOGICAL;

RATTUS;

EID: 79954451014     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0388-8     Document Type: Article

References (40)

1. EG Krug GK Sharma R Lozano 2000 The global burden of injuries Am J Public Health 90 523 526 10754963 10.2105/AJPH.90.4.523 1:STN:280: DC%2BD3c3hslOltw%3D%3D (Pubitemid 30167408)
2. RJ Waxweiler D Thurman J Sniezek D Sosin J O'Neil 1995 Monitoring the impact of traumatic brain injury: a review and update J Neurotrauma 12 509 516 8683602 10.1089/neu.1995.12.509 1:STN:280:DyaK287hs1aitQ%3D%3D
3. J Castillo A Davalos J Naveiro M Noya 1996 Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke Stroke 27 1060 1065 8650715 1:STN:280:DyaK283ktVKjtw%3D%3D (Pubitemid 26177607)
4. J Castillo A Davalos M Noya 1997 Progression of ischaemic stroke and excitotoxic aminoacids Lancet 349 79 83 8996418 10.1016/S0140-6736(96)04453-4 1:STN:280:DyaK2s7kvFKisg%3D%3D (Pubitemid 27023423)
5. MV Johnston WH Trescher A Ishida W Nakajima 2001 Neurobiology of hypoxic-ischemic injury in the developing brain Pediatr Res 49 735 741 11385130 10.1203/00006450-200106000-00003 1:CAS:528:DC%2BD3MXltVOitLs%3D (Pubitemid 32522044)
6. A Zauner R Bullock AJ Kuta J Woodward HF Young 1996 Glutamate release and cerebral blood flow after severe human head injury Acta Neurochir Suppl 67 40 44 8870800 1:STN:280:DyaK2s%2FisVGksA%3D%3D (Pubitemid 126446200)
7. C Ferrarese A Aliprandi L Tremolizzo L Stanzani A De Micheli A Dolara L Frattola 2001 Increased glutamate in CSF and plasma of patients with HIV dementia Neurology 57 671 675 11524477 1:CAS:528:DC%2BD3MXmslymt74%3D (Pubitemid 32782996)
8. PJ Shaw V Forrest PG Ince JP Richardson HJ Wastell 1995 CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients Neurodegeneration 4 209 216 7583686 10.1006/neur.1995.0026 1:STN:280:DyaK28%2FmtFentQ%3D%3D
9. M Spranger S Krempien S Schwab M Maiwald K Bruno W Hacke 1996 Excess glutamate in the cerebrospinal fluid in bacterial meningitis J Neurol Sci 143 126 131 8981310 10.1016/S0022-510X(96)00197-9 1:CAS:528:DyaK2sXisFOrtw%3D%3D (Pubitemid 26402798)
10. SS Koura EM Doppenberg A Marmarou S Choi HF Young R Bullock 1998 Relationship between excitatory amino acid release and outcome after severe human head injury Acta Neurochir Suppl 71 244 246 9779196 1:STN:280: DyaK1cvlt1aiug%3D%3D (Pubitemid 128444409)
11. H Zhang X Zhang T Zhang L Chen 2001 Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries Clin Chem 47 1458 1462 11468237 1:STN:280:DC%2BD3MvjtV2jtg%3D%3D
12. RL O'Kane I Martinez-Lopez MR DeJoseph JR Vina RA Hawkins 1999 Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal J Biol Chem 274 31891 31895 10542215 10.1074/jbc.274.45.31891 (Pubitemid 29522919)
13. VI Teichberg K Cohen-Kashi-Malina I Cooper A Zlotnik 2009 Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies Neuroscience 158 301 308 18423998 10.1016/j.neuroscience.2008. 02.075 1:CAS:528:DC%2BD1MXns1ygug%3D%3D
14. M Gottlieb Y Wang VI Teichberg 2003 Blood-mediated scavenging of cerebrospinal fluid glutamate J Neurochem 87 119 126 12969259 10.1046/j.1471-4159.2003.01972.x 1:CAS:528:DC%2BD3sXotFSksbg%3D (Pubitemid 37210646)
15. JF Stover OS Kempski 2005 Anesthesia increases circulating glutamate in neurosurgical patients Acta Neurochir (Wien) 147 847 853 10.1007/s00701-005- 0562-y 1:STN:280:DC%2BD2MzovFOntg%3D%3D (Pubitemid 41103961)
16. A Zlotnik Y Klin R Kotz M Dubilet M Boyko S Ohayon Y Shapira VI Teichberg 2010 Regulation of blood L-glutamate levels by stress as a possible brain defense mechanism Exp Neurol 224 465 471 20493841 10.1016/j.expneurol.2010.05. 009 1:CAS:528:DC%2BC3cXovFCgt7o%3D
17. LT Graham Jr MH Aprison 1966 Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods Anal Biochem 15 487 497 4381042 10.1016/0003-2697(66)90110-2 1:CAS:528: DyaF28Xkt1alu7w%3D
18. KM Wilson MJ Fregly 1985 Angiotensin II-induced hypothermia in rats J Appl Physiol 58 534 543 3884574 1:CAS:528:DyaL2MXht1Kgtr8%3D (Pubitemid 15057767)
19. AM Schneider NS Koven KA Lombardo DA Levin PE Simson 2000 Beta-adrenergic receptor blockade by propranolol enhances retention in a multitrial passive-avoidance procedure Behav Neurosci 114 1256 1260 11142659 10.1037/0735-7044.114.6.1256 1:CAS:528:DC%2BD3MXitFWhtw%3D%3D
20. F Fiordaliso N De Angelis A Bai I Cuccovillo M Salio DM Serra R Bianchi R Razzetti R Latini S Masson 2007 Effect of beta-adrenergic and renin-angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats Life Sci 81 951 959 17825849 10.1016/j.lfs.2007.05.027 1:CAS:528:DC%2BD2sXhtVCmtbfE
21. D Keenan A Romani A Scarpa 1995 Differential regulation of circulating Mg2 + in the rat by beta 1- and beta 2-adrenergic receptor stimulation Circ Res 77 973 983 7554152 1:CAS:528:DyaK2MXovVKrtLY%3D
22. TY Tran IE Dunne JW German 2008 Beta blockers exposure and traumatic brain injury: a literature review Neurosurg Focus 25 E8 18828706 10.3171/FOC.2008.25.10.E8
23. PD Woolf RW Hamill LA Lee C Cox JV McDonald 1987 The predictive value of catecholamines in assessing outcome in traumatic brain injury J Neurosurg 66 875 882 3572517 10.3171/jns.1987.66.6.0875 1:STN:280:DyaL2s7pslGqtA%3D%3D (Pubitemid 17085709)
24. A Zlotnik B Gurevich E Cherniavsky S Tkachov A Matuzani-Ruban A Leon Y Shapira VI Teichberg 2007 The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury Neurochem Res 33 1044 1050 18080187 10.1007/s11064-007-9548-x
25. A Zlotnik B Gurevich S Tkachov I Maoz Y Shapira VI Teichberg 2007 Brain neuroprotection by scavenging blood glutamate Exp Neurol 203 213 220 17014847 10.1016/j.expneurol.2006.08.021 1:CAS:528:DC%2BD28Xht1Krt73N (Pubitemid 44821179)
26. A Zlotnik SE Gruenbaum AA Artru I Rozet M Dubilet S Tkachov E Brotfain Y Klin Y Shapira VI Teichberg 2009 The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate J Neurosurg Anesthesiol 21 235 241 19543002 10.1097/ANA.0b013e3181a2bf0b
27. C Berger A Stauder F Xia C Sommer S Schwab 2008 Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia Exp Neurol 210 543 548 18187132 10.1016/j.expneurol.2007.12. 002 1:CAS:528:DC%2BD1cXksVKrs7o%3D
28. M Farooque L Hillered A Holtz Y Olsson 1996 Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: an experimental study in the rat using microdialysis J Neurotrauma 13 537 548 8913970 10.1089/neu.1996.13.537 1:STN:280:DyaK2s%2FntFSntg%3D%3D (Pubitemid 26366882)
29. LL Guyot FG Diaz MH O'Regan S McLeod H Park JW Phillis 2001 Real-time measurement of glutamate release from the ischemic penumbra of the rat cerebral cortex using a focal middle cerebral artery occlusion model Neurosci Lett 299 37 40 11166932 10.1016/S0304-3940(01)01510-5 1:CAS:528:DC%2BD3MXpsFyhuw%3D%3D (Pubitemid 32146339)
30. JL Han R Kollmar B Tobyas S Schwab 2008 Inhibited glutamate release by granulocyte-colony stimulating factor after experimental stroke Neurosci Lett 432 167 169 18255224 10.1016/j.neulet.2007.07.056 1:CAS:528:DC%2BD1cXitVaqt7c%3D
31. Y Zhang H Zhang PJ Feustel HK Kimelberg 2008 DCPIB, a specific inhibitor of volume regulated anion channels (VRACs), reduces infarct size in MCAo and the release of glutamate in the ischemic cortical penumbra Exp Neurol 210 514 520 18206872 10.1016/j.expneurol.2007.11.027 1:CAS:528:DC%2BD1cXksVKrs7w%3D
32. A Zlotnik B Gurevich E Cherniavsky S Tkachov A Matuzani-Ruban A Leon Y Shapira VI Teichberg 2008 The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury Neurochem Res 33 1044 1050 18080187 10.1007/s11064-007-9548-x 1:CAS:528:DC%2BD1cXks1GgurY%3D
33. EP Rutten MP Engelen AM Schols NE Deutz 2005 Skeletal muscle glutamate metabolism in health and disease: state of the art Curr Opin Clin Nutr Metab Care 8 41 51 15585999 10.1097/00075197-200501000-00007 1:CAS:528: DC%2BD2MXhsVyltL4%3D (Pubitemid 40204444)
34. A Thomassen TT Nielsen JP Bagger P Henningsen 1991 Effects of intravenous glutamate on substrate availability and utilization across the human heart and leg Metabolism 40 378 384 2011078 10.1016/0026-0495(91)90148-P 1:STN:280:DyaK3M7os1yntw%3D%3D
35. Morris GF, Juul N, Marshall SB, Benedict B, Marshall LF (1998) Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive committee of the international selfotel trial. Neurosurgery 43:1372-1374; discussion
36. KW Muir 2006 Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists Curr Opin Pharmacol 6 53 60 16359918 10.1016/j.coph.2005.12. 002 1:CAS:528:DC%2BD28XmsVygtg%3D%3D (Pubitemid 43103819)
37. KW Muir KR Lees 1995 Clinical experience with excitatory amino acid antagonist drugs Stroke 26 503 513 7886734 1:STN:280:DyaK2M7ptlSjsA%3D%3D
38. C Ikonomidou L Turski 2002 Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1 383 386 12849400 10.1016/S1474-4422(02)00164-3 1:CAS:528:DC%2BD3sXkvFKrtr8%3D (Pubitemid 37159164)
39. GE Hardingham H Bading 2003 The Yin and Yang of NMDA receptor signalling Trends Neurosci 26 81 89 12536131 10.1016/S0166-2236(02)00040-1 1:CAS:528:DC%2BD3sXkvVygsw%3D%3D (Pubitemid 36110542)
40. A Biegon PA Fry CM Paden A Alexandrovich J Tsenter E Shohami 2004 Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits Proc Natl Acad Sci USA 101 5117 5122 15044697 10.1073/pnas.0305741101 1:CAS:528: DC%2BD2cXjsFCisbc%3D (Pubitemid 38469212)